References
- Kane J. The facilitation of early detection and treatment of schizophrenia. Current Opinion in Psychiatry 1997; 10: 3–4
- Fentort W. Course and outcome in schizophrenia. Current Opinion in Psychiatry 1997; 10: 40–44
- Gow T, MacMillan J, Johnson A, Johnstone E. A randomised controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry 1986; 148: 120–127
- Lieberman J, Jody D, Geister S, Vital-Hene J, Alvir J, Woerner M. Treatment outcome of first-episode schizophrenia. Psychopharmacology Bulletin 1989; 25: 92–96
- McGorry P. Early psychosis prevention and intervention centre. Australasian Psychiatry 1993; 1: 32–34
- Rakfeldt J, McGlashan T. Outset, course, and outcome of schizophrenia. Current Opinion in Psychiatry 1996; 9: 73–76
- Birchwood M, Macmillan F. Early intervention in schizophrenia. Australian and New Zealand Journal of Psychiatry 1993; 27: 374–378
- Harrison G, Goudace T, Mason P, Glazebrook C, Medley I. Predicting the long-term outcome of schizophrenia. Psychological Medicine 1996; 26: 697–705
- Larsen T, McGlashan T, Moe L. First episode schizophrenia: 1. Early course parameters. Schizophrenia Bulletin 1996; 22: 241–256
- Szymanski S, Cannon T, Gollacher F, Erwin R, Gur R. Course and treatment response in first-episode and chronic schizophrenia. American Journal of Psychiatry 1996; 153: 519–525
- Loeb A, Lieberman J, Alvir J, Myerhoff D, Geisler S, Szymanski S. Duration of psychosis and outcome in first-episode schizophrenia. American Journal of Psychiatry 1992; 149: 1183–1188
- Waddington J, Youssef H, Kinsella A. Sequential cross-sectional and 20-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychological Medicine 1995; 25: 849–857
- Bleuler M. The schizophrenic disorders. Long-term patient and family studies. Yale University Press, New Haven 1978
- Harding C, Brooks G, Ashikaga T, Strauss Breier A. The Vermont Longitudinal Study: Long term outcome for subjects who retrospectively met DSM-III criteria for schizophrenia. American Journal of Psychiatry 1987; 144: 71–78
- Harding C, Zahniser J. Empirical correction of seven myths about schizophrenia with implications for treatment. Acta Psychiatrica Scandinavica 1994; 90(Suppl. 384)140–146
- Desisto M, Harding C, McCormick R, Ashikaga T, Brooks G. The Mame-Vermont three decade studies of serious mental illness: matched comparison of cross-sectional outcome. British Journal of Psychiatry 1996; 167: 331–341
- Jeste D. Late-onset schizophrenia. International Journal of Geriatric Psychiatry 1993; 8: 283–285
- Almeida O, Howard R, Levy R, David A. Psychotic states arising in late life (late paraphrenia), psychopathology and nosology. British Journal of Psychiatry 1995; 166: 205–214
- Howard R, Levy R. Late-onset schizophrenia, late paraphrenia and paranoid states of late life. Psychiatry in the elderly2nd ed., R Jacoby, C Oppenheimer. Oxford University Press, Edinburgh 1997; 617–631
- Rabins P, Pauker S, Thorns J. Can schizophrenia begin after age 44?. Comprehensive Psychiatry 1984; 25: 290–293
- Pearlson G, Kreger L, Rabins P, Chase G. A chart review study of late-onset and early-onset schizophrenia. American Journal of Psychiatry 1989; 146: 1568–1574
- Howard R, Levy R. Which factors affect treatment response in late paraphrenia?. International Journal of Geriatric Psychiatry 1992; 7: 667–672
- Little J. Intervention and social breakdown in the elderly. Australian and New Zealand Journal of Psychiatry 1996; 30: 681–684
- Birley J. Psychiatrists and citizens. British Journal of Psychiatry 1991; 159: 1
- Raskind M, Risse S. Antipsychotic drugs and the elderly. Journal of Clinical Psychiatry 1986; 47: 17–22
- Jeste D, Eastham J, Gierz M, Field M, Morgenstern M, Lacro J. Use of risperidone in the elderly. The art of rational risperidone therapy, F Ayd. Ayd Medical Communications, Baltimore, MD 1997; 147–167
- Jeste D, Caligiuri M, Paulsen J, et al. Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 patients. Archives of General Psychiatry 1995; 52: 756–765
- Avorn J, Bohn R, Mogun H, et al. Neuroleptic drug exposure and treatment of Parkinsonism in the elderly: a case-control study. American Journal of Medicine 1995; 99: 48–54